{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:40:23Z","timestamp":1791826823703,"version":"4.3.4"},"reference-count":48,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of General Medical Sciences (NIGMS) COBRE","award":["2P20 GM109024"],"award-info":[{"award-number":["2P20 GM109024"]}]},{"name":"Engebretson Family Research Fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) remains one of the most aggressive malignancies, with limited response to conventional chemotherapies such as paclitaxel (PTX) due to poor solubility, low bioavailability, and systemic toxicity. To address these limitations, this study explores mesenchymal stem cell (MSC)-derived exosomes as biocompatible, tumor-homing nanocarriers for PTX delivery. Exosomes were isolated from MSC-conditioned media using ultracentrifugation and tangential flow filtration (TFF), with TFF yielding 8 to 9-fold higher exosome recovery. Flow cytometry confirmed the presence of exosomal (CD63, CD81) and MSC (CD90) surface markers, while transmission electron microscopy and dynamic light scattering revealed spherical vesicles averaging ~160 nm in diameter with a zeta potential of approximately \u221228 mV. PTX was loaded into exosomes using ultrasonication, achieving an encapsulation efficiency of 31.3 \u00b1 2.0%, and release studies showed an initial burst within 24 h followed by sustained release over 7 days. Blank exosomes exhibited no cytotoxicity toward PANC-1, BxPC-3, and HPNE cells, confirming their excellent biocompatibility. In contrast, PTX-loaded exosomes significantly enhanced cytotoxicity compared to free PTX, reducing IC50 values from 12.48 nM to 7.55 nM in BxPC-3 cells and from 22.44 nM to 19.29 nM in PANC-1 cells and suppressed colony formation and spheroid growth more effectively. These findings demonstrate that MSC-derived exosomes can efficiently encapsulate and deliver PTX, enhancing its antitumor efficacy. This exosome-based platform offers a promising strategy to overcome pharmacological barriers and improve therapeutic outcomes in PDAC.<\/jats:p>","DOI":"10.3390\/biom16020269","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T09:41:02Z","timestamp":1770630062000},"page":"269","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Mesenchymal Stem Cell Exosome-Mediated Delivery of Paclitaxel for Pancreatic Cancer Therapy"],"prefix":"10.3390","volume":"16","author":[{"given":"Anurag","family":"Banerjee","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Ghosal","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2039-4864","authenticated-orcid":false,"given":"Paras Mani","family":"Giri","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakurako","family":"Tani","sequence":"additional","affiliation":[{"name":"Department of Physics, North Dakota State University, Fargo, ND 58102, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongki","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Physics, North Dakota State University, Fargo, ND 58102, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2457-7619","authenticated-orcid":false,"given":"Buddhadev","family":"Layek","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, North Dakota State University, Fargo, ND 58105, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"ref_1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gheorghe, G., Bungau, S., Ilie, M., Behl, T., Vesa, C.M., Brisc, C., Bacalbasa, N., Turi, V., Costache, R.S., and Diaconu, C.C. (2020). Early Diagnosis of Pancreatic Cancer: The Key for Survival. Diagnostics, 10.","DOI":"10.3390\/diagnostics10110869"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e2005993","DOI":"10.1002\/smll.202005993","article-title":"Development of Facile and Versatile Platinum Drug Delivering Silicasome Nanocarriers for Efficient Pancreatic Cancer Chemo-Immunotherapy","volume":"17","author":"Liu","year":"2021","journal-title":"Small"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.clinthera.2017.08.015","article-title":"Current Standards of Chemotherapy for Pancreatic Cancer","volume":"39","author":"Saung","year":"2017","journal-title":"Clin. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Giri, P.M., Banerjee, A., and Layek, B. (2023). A Recent Review on Cancer Nanomedicine. Cancers, 15.","DOI":"10.3390\/cancers15082256"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.pbiomolbio.2025.02.003","article-title":"Advancing targeted therapies in pancreatic cancer: Leveraging molecular abberrations for therapeutic success","volume":"196","author":"Gupta","year":"2025","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Principe, D.R., Underwood, P.W., Korc, M., Trevino, J.G., Munshi, H.G., and Rana, A. (2021). The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.688377"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"9205","DOI":"10.3390\/curroncol30100665","article-title":"Toxicities and Quality of Life during Cancer Treatment in Advanced Solid Tumors","volume":"30","author":"Lee","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.trecan.2022.08.005","article-title":"Mechanisms of PDAC subtype heterogeneity and therapy response","volume":"8","author":"Espinet","year":"2022","journal-title":"Trends Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"116492","DOI":"10.1016\/j.bcp.2024.116492","article-title":"Overcoming therapy resistance in pancreatic cancer: New insights and future directions","volume":"229","author":"Patthey","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.21873\/anticanres.13026","article-title":"Targeted Therapies for Pancreatic Cancer and Hurdles Ahead","volume":"38","author":"Aslan","year":"2018","journal-title":"Anticancer. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"106035","DOI":"10.1016\/j.jddst.2024.106035","article-title":"Development of cationic pH-sensitive liposomes with Gemcitabine loading and Fucoidan-coating against pancreatic cancer cells","volume":"100","author":"Zhou","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.2174\/1381612826666200622133407","article-title":"Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy","volume":"26","author":"Layek","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s44276-025-00130-9","article-title":"Solid lipid nanoparticles in pancreatic cancer treatment","volume":"3","author":"Dunn","year":"2025","journal-title":"BJC Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"116743","DOI":"10.1016\/j.biopha.2024.116743","article-title":"Nanocarrier mediated entinostat and oxaliplatin combination therapy displayed enhanced efficacy against pancreatic cancer","volume":"175","author":"Giri","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"102153","DOI":"10.1016\/j.mtbio.2025.102153","article-title":"A polymeric nanovesicle delivers sulfopin and gemcitabine to remodel tumor microenvironment for enhanced chemoimmunotherapy against orthotopic pancreatic cancer","volume":"34","author":"Jiang","year":"2025","journal-title":"Mater. Today Bio"},{"key":"ref_18","first-page":"368","article-title":"Smart polymeric nanoparticles for targeted delivery and microenvironment-responsive therapy in pancreatic cancer","volume":"6","author":"Kar","year":"2025","journal-title":"Smart Mater. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"112277","DOI":"10.1016\/j.inoche.2024.112277","article-title":"Silver nanoparticles green-formulated by a medicinal plant for the treatment of pancreatic, colorectal, and gastric cancers","volume":"163","author":"Li","year":"2024","journal-title":"Inorg. Chem. Commun."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s44395-025-00018-0","article-title":"Innovative nanoparticle-based therapies for pancreatic neuroendocrine tumours (PNETs): Advances, challenges, and future directions","volume":"1","author":"Akunne","year":"2025","journal-title":"Discov. Pharm. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101555","DOI":"10.1016\/j.mtbio.2025.101555","article-title":"Enzyme-responsive vitamin D-based micelles for paclitaxel-controlled delivery and synergistic pancreatic cancer therapy","volume":"31","author":"Peixoto","year":"2025","journal-title":"Mater. Today Bio"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"124529","DOI":"10.1016\/j.ijpharm.2024.124529","article-title":"Cancer cell membrane-modified Soluplus\u00ae micelles for gemcitabine delivery to pancreatic cancer using a prodrug approach","volume":"662","author":"Veiga","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejpb.2021.11.005","article-title":"Peptide dendrimers as potentiators of conventional chemotherapy in the treatment of pancreatic cancer in a mouse model","volume":"170","author":"Huang","year":"2022","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_24","first-page":"100002","article-title":"Dendrimer-based nanoplatforms for enhanced mRNA delivery: From rational structural design to formulation strategies","volume":"1","author":"Xiao","year":"2025","journal-title":"Adv. Interv. Mater."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1008126","DOI":"10.37349\/eds.2025.1008126","article-title":"Challenges in drug delivery to the tumors\u2014Nanoparticles in medicine","volume":"3","author":"Koszarska","year":"2025","journal-title":"Explor. Drug Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e2312169","DOI":"10.1002\/adma.202312169","article-title":"Nanomedicine Tumor Targeting","volume":"36","author":"Lammers","year":"2024","journal-title":"Adv. Mater."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"103628","DOI":"10.1016\/j.critrevonc.2022.103628","article-title":"New advances in exosome-based targeted drug delivery systems","volume":"172","author":"Ferreira","year":"2022","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"107453","DOI":"10.1016\/j.jddst.2025.107453","article-title":"Exosome-based drug delivery in cancer therapy: Advances and future perspectives","volume":"114","author":"Maghami","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"216093","DOI":"10.1016\/j.canlet.2023.216093","article-title":"Tumor-targeted exosomes for delivery of anticancer drugs","volume":"558","author":"Raguraman","year":"2023","journal-title":"Cancer Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jconrel.2024.02.037","article-title":"Smart exosomes enhance PDAC targeted therapy","volume":"368","author":"Creeden","year":"2024","journal-title":"J. Control. Release"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Di Bella, M.A. (2022). Overview and Update on Extracellular Vesicles: Considerations on Exosomes and Their Application in Modern Medicine. Biology, 11.","DOI":"10.3390\/biology11060804"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-024-02215-4","article-title":"Emerging role of exosomes in cancer therapy: Progress and challenges","volume":"24","author":"Li","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_34","first-page":"102313","article-title":"Engineered mesenchymal stem cell-derived exosomes: A revolutionary approach to unlocking liver disease treatment","volume":"44","author":"Kheirkhah","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s40001-023-01556-y","article-title":"Mesenchymal stem cells-derived exosomes: Novel carriers for nanoparticle to combat cancer","volume":"28","author":"Abbasi","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"814","DOI":"10.4252\/wjsc.v12.i8.814","article-title":"Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine","volume":"12","author":"Ma","year":"2020","journal-title":"World J. Stem. Cells"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"20360","DOI":"10.3402\/jev.v2i0.20360","article-title":"Standardization of sample collection, isolation and analysis methods in extracellular vesicle research","volume":"2","author":"Witwer","year":"2013","journal-title":"J. Extracell. Vesicles"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1900043","DOI":"10.1002\/adtp.201900043","article-title":"Nanoengineering of Mesenchymal Stem Cells via Surface Modification for Efficient Cancer Therapy","volume":"2","author":"Layek","year":"2019","journal-title":"Adv. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wang, X., Li, D., Li, G., Chen, J., Yang, Y., Bian, L., Zhou, J., Wu, Y., and Chen, Y. (2024). Enhanced Therapeutic Potential of Hybrid Exosomes Loaded with Paclitaxel for Cancer Therapy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25073645"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"107341","DOI":"10.1016\/j.jddst.2025.107341","article-title":"Panobinostat-Loaded Albumin Nanoparticles for the Treatment of Pancreatic Cancer","volume":"113","author":"Giri","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.14227\/DT190112P6","article-title":"KinetDS: An open source software for dissolution test data analysis","volume":"19","author":"Mendyk","year":"2012","journal-title":"Dissolut. Technol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Busatto, S., Vilanilam, G., Ticer, T., Lin, W.L., Dickson, D.W., Shapiro, S., Bergese, P., and Wolfram, J. (2018). Tangential Flow Filtration for Highly Efficient Concentration of Extracellular Vesicles from Large Volumes of Fluid. Cells, 7.","DOI":"10.3390\/cells7120273"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cjprs.2025.05.001","article-title":"Recent advances in scalable exosome production: Challenges and innovations","volume":"7","author":"Chen","year":"2025","journal-title":"Chin. J. Plast. Reconstr. Surg."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1208\/s12249-024-02922-7","article-title":"A Comparative Mathematical Analysis of Drug Release from Lipid-Based Nanoparticles","volume":"25","author":"Porbaha","year":"2024","journal-title":"AAPS PharmSciTech"},{"key":"ref_45","first-page":"177","article-title":"Mesenchymal stem cell-derived exosomes do not promote the proliferation of cancer cells in vitro","volume":"11","author":"Karaoz","year":"2019","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13045-022-01305-4","article-title":"Emerging role of exosomes in cancer progression and tumor microenvironment remodeling","volume":"15","author":"Paskeh","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"102920","DOI":"10.1016\/j.nantod.2025.102920","article-title":"Rational design of extracellular vesicles for targeted drug delivery across physiological barriers","volume":"66","author":"Baby","year":"2026","journal-title":"Nano Today"},{"key":"ref_48","first-page":"100349","article-title":"Plant-derived extracellular vesicles as a natural drug delivery platform for glioblastoma therapy: A dual role in preserving endothelial integrity while modulating the tumor microenvironment","volume":"10","author":"Cui","year":"2025","journal-title":"Int. J. Pharm. X"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/2\/269\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T10:16:18Z","timestamp":1770632178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/16\/2\/269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["biom16020269"],"URL":"https:\/\/doi.org\/10.3390\/biom16020269","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]}}}